149 related articles for article (PubMed ID: 37328100)
1. Fibrotic Matrix Induces Mesenchymal Transformation of Epithelial Cells in Oral Submucous Fibrosis.
Xu HQ; Guo ZX; Yan JF; Wang SY; Gao JL; Han XX; Qin WP; Lu WC; Gao CH; Zhu WW; Fu YT; Jiao K
Am J Pathol; 2023 Sep; 193(9):1208-1222. PubMed ID: 37328100
[TBL] [Abstract][Full Text] [Related]
2. Role of the arecoline/YAP1/BMP4 pathway in promoting endothelial-mesenchymal transition in oral submucous fibrosis.
Yao M; Li J; Yuan S; Zhu X; Hu Z; Li Q; Cao R; Wang W; Fang C
J Oral Pathol Med; 2020 Apr; 49(4):305-310. PubMed ID: 31397922
[TBL] [Abstract][Full Text] [Related]
3. DPSCs regulate epithelial-T cell interactions in oral submucous fibrosis.
Wang SY; Zhang SJ; Meng HF; Xu HQ; Guo ZX; Yan JF; Gao JL; Niu LN; Wang SL; Jiao K
Stem Cell Res Ther; 2024 Apr; 15(1):113. PubMed ID: 38650025
[TBL] [Abstract][Full Text] [Related]
4. YAP-Induced Endothelial-Mesenchymal Transition in Oral Submucous Fibrosis.
Li J; Yao M; Zhu X; Li Q; He J; Chen L; Wang W; Zhu C; Shen T; Cao R; Fang C
J Dent Res; 2019 Jul; 98(8):920-929. PubMed ID: 31282845
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of Notch Suppresses Epithelial-mesenchymal Transition and Induces Angiogenesis in Oral Submucous Fibrosis by Regulating TGF-β1.
Wang J; Yang L; Mei J; Li Z; Huang Y; Sun H; Zheng K; Kuang H; Luo W
Biochem Genet; 2024 Apr; 62(2):1055-1069. PubMed ID: 37526864
[TBL] [Abstract][Full Text] [Related]
6. Oral submucous fibrosis stimulates invasion and epithelial-mesenchymal transition in oral squamous cell carcinoma by activating MMP-2 and IGF-IR.
Chen PN; Lin CW; Yang SF; Chang YC
J Cell Mol Med; 2021 Oct; 25(20):9814-9825. PubMed ID: 34528373
[TBL] [Abstract][Full Text] [Related]
7. Slug mediates myofibroblastic differentiation to promote fibrogenesis in buccal mucosa.
Fang CY; Hsia SM; Hsieh PL; Liao YW; Peng CY; Wu CZ; Lin KC; Tsai LL; Yu CC
J Cell Physiol; 2019 May; 234(5):6721-6730. PubMed ID: 30230545
[TBL] [Abstract][Full Text] [Related]
8. Tanshinone Suppresses Arecoline-Induced Epithelial-Mesenchymal Transition in Oral Submucous Fibrosis by Epigenetically Reactivating the p53 Pathway.
Zheng L; Guan ZJ; Pan WT; Du TF; Zhai YJ; Guo J
Oncol Res; 2018 Apr; 26(3):483-494. PubMed ID: 28550687
[TBL] [Abstract][Full Text] [Related]
9. Arecoline-induced myofibroblast transdifferentiation from human buccal mucosal fibroblasts is mediated by ZEB1.
Chang YC; Tsai CH; Lai YL; Yu CC; Chi WY; Li JJ; Chang WW
J Cell Mol Med; 2014 Apr; 18(4):698-708. PubMed ID: 24400868
[TBL] [Abstract][Full Text] [Related]
10. Nanomechanical signatures of oral submucous fibrosis in sub-epithelial connective tissue.
Anura A; Das D; Pal M; Paul RR; Das S; Chatterjee J
J Mech Behav Biomed Mater; 2017 Jan; 65():705-715. PubMed ID: 27750161
[TBL] [Abstract][Full Text] [Related]
11. The Role of Increased Connective Tissue Growth Factor in the Pathogenesis of Oral Submucous Fibrosis and its Malignant Transformation-An Immunohistochemical Study.
Shah AM; Jain K; Desai RS; Bansal S; Shirsat P; Prasad P; Bodhankar K
Head Neck Pathol; 2021 Sep; 15(3):817-830. PubMed ID: 33544386
[TBL] [Abstract][Full Text] [Related]
12. Augmented mRNA expression of tissue inhibitor of metalloproteinase-1 in buccal mucosal fibroblasts by arecoline and safrole as a possible pathogenesis for oral submucous fibrosis.
Shieh DH; Chiang LC; Shieh TY
Oral Oncol; 2003 Oct; 39(7):728-35. PubMed ID: 12907213
[TBL] [Abstract][Full Text] [Related]
13. Role of Yes-associated protein and transcriptional coactivator with PDZ-binding motif in the malignant transformation of oral submucous fibrosis.
Sharma M; Hunter KD; Fonseca FP; Shetty SS; Radhakrishnan R
Arch Oral Biol; 2021 Aug; 128():105164. PubMed ID: 34044344
[TBL] [Abstract][Full Text] [Related]
14. Butylidenephthalide abrogates the myofibroblasts activation and mesenchymal transdifferentiation in oral submucous fibrosis.
Su TR; Liao YW; Hsieh PL; Tsai LL; Fang CY; Lin T; Lee YH; Harn HJ; Yu CC
Environ Toxicol; 2018 Jun; 33(6):686-694. PubMed ID: 29665273
[TBL] [Abstract][Full Text] [Related]
15. Epithelio-mesenchymal transitional attributes in oral sub-mucous fibrosis.
Das RK; Anura A; Pal M; Bag S; Majumdar S; Barui A; Chakraborty C; Ray AK; Sengupta S; Paul RR; Chatterjee J
Exp Mol Pathol; 2013 Dec; 95(3):259-69. PubMed ID: 23994666
[TBL] [Abstract][Full Text] [Related]
16. A biomaterial-based therapy using a sodium hyaluronate/bioglass composite hydrogel for the treatment of oral submucous fibrosis.
Guo ZX; Zhang Z; Yan JF; Xu HQ; Wang SY; Ye T; Han XX; Wang WR; Wang Y; Gao JL; Niu LN; Chang J; Jiao K
Acta Biomater; 2023 Feb; 157():639-654. PubMed ID: 36509401
[TBL] [Abstract][Full Text] [Related]
17. Silencing periostin inhibits myofibroblast transdifferentiation of fibrotic buccal mucosal fibroblasts.
Su JY; Yu CC; Peng CY; Liao YW; Hsieh PL; Yang LC; Yu CH; Chou MY
J Formos Med Assoc; 2021 Nov; 120(11):2010-2015. PubMed ID: 33965260
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of stromal myofibroblasts in oral submucous fibrosis and its malignant transformation: An immunohistochemical study.
Liu Z; Hu W; Shan Z; Liu S; Yao Z; Quan H
J Cancer Res Ther; 2024 Apr; 20(2):706-711. PubMed ID: 38687943
[TBL] [Abstract][Full Text] [Related]
19. PDE12 disrupts mitochondrial oxidative phosphorylation and mediates mitochondrial dysfunction to induce oral mucosal epithelial barrier damage in oral submucous fibrosis.
Wei Q; Chen L; Luo W; Chen C; Shi Y; Xie J; Xie X; Luo HB
Eur J Pharmacol; 2024 Mar; 967():176353. PubMed ID: 38325798
[TBL] [Abstract][Full Text] [Related]
20. Elevation of Twist expression by arecoline contributes to the pathogenesis of oral submucous fibrosis.
Lee YH; Yang LC; Hu FW; Peng CY; Yu CH; Yu CC
J Formos Med Assoc; 2016 May; 115(5):311-7. PubMed ID: 26088962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]